Thiophen-2-ylsulfonyl indole-3-carbaldehyde thiosemicarbazones as selective prostate cancer agents: biological profiling and molecular targeting studies
= 7.96 and 5.30 µM, respectively). These synthesized compounds showed preferential activity towards prostate cancer (LNCaP) cells specifically in comparison with lung cancer A549 cells. Thus, subsequent computational studies were directed to the molecular targets associated with prostate cancer. The docking study of compounds 5b-5d against AR, EGFR, VEGFR-2, AKT1, mTOR, and PI3Kα, followed by MM-GBSA analysis, indicated their good binding activity with particular reference to the AR target. An MD simulation of 250 ns on the AR-compound 5d complex confirmed the stability and constant interaction with important residues. ADME and DFT analyses determined the properties of the selected compounds. Overall, compound 5d emerged as a promising lead for further investigation against prostate cancer. Our data provide a foundation for the rational design and optimization of thiosemicarbazone-based anticancer agents and advance research into their molecular mechanisms, target selectivity, and preclinical therapeutic potential.
Authors
- Halil Şenol (ORCID: https://orcid.org/0000-0002-8333-035X)
- Abdullah F. Alasmari (ORCID: https://orcid.org/0000-0001-7569-4287)
- Abdulrahman Alshammari (ORCID: https://orcid.org/0000-0002-9888-9826)
- Hande İpek Yetke (ORCID: https://orcid.org/0009-0006-9681-1271)
- Asif Rasool (ORCID: https://orcid.org/0000-0003-2769-7568)
- Zahid Shafiq (ORCID: https://orcid.org/0000-0003-4088-8297)
- Ayşe Merve Şenol (ORCID: https://orcid.org/0000-0003-3355-8222)
- Metab Alharbi (ORCID: https://orcid.org/0000-0001-8287-4470)
- Kazma Batool
- Fatma Ateş
Institutions
- Bahauddin Zakariya University (PK)
- King Saud University (SA)
- Bezmiâlem Vakıf Üniversitesi (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- Nanjing University (CN)
Publication Details
- Journal
- RSC Advances
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1039/d6ra08602k
- Primary Topic
- Heterocyclic Compound Synthesis and Bioactivity
- Type
- article
- Field-Weighted Citation Impact
- 0.00